Epigenomic biomonitors: Global DNA hypomethylation as a biodosimeter of life-long environmental exposures

Epigenomics

Volumn 3, Issue 1, 2011, Pages 1-5

  Guerrero Preston, Rafael ^a   Herbstman, Julie ^b   Goldman, Lynn R ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Mailman School of Public Health ^*  (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

biomonitoring devices; epigenomics; exposome; global DNA hypomethylation; molecular biodosimeters

Indexed keywords

DNA;

BIOLOGICAL MONITORING; CPG ISLAND; DNA METHYLATION; DOSIMETRY; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENOME; GENOME IMPRINTING; GENOMIC INSTABILITY; HEALTH PRACTITIONER; HUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; TELECOMMUNICATION;

BIOLOGICAL MARKERS; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENESIS, GENETIC; EPIGENOMICS; GROWTH AND DEVELOPMENT; HUMANS;

EID: 79951919529     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.77     Document Type: Review

References (20)

1. Wild CP: Complementing the genome with an 'exposome': the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomarkers Prev. 14(8), 1847-1850 (2005). (Pubitemid 41161186)
2. Herceg Z: Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22(2), 91-103 (2007). (Pubitemid 46364521)
3. Portela A, Esteller M: Epigenetic modifications and human disease. Nat. Biotechnol. 28(10), 1057-1068 (2010).
4. Berdasco M, Esteller M: Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell. 19(5), 698-711 (2010).
5. Brown SE, Fraga MF, Weaver IC, Berdasco M, Szyf M: Variations in DNA methylation patterns during the cell cycle of HeLa cells. Epigenetics 2(1), 54-65 (2007). (Pubitemid 46830295)
6. Gluckman PD, Hanson MA, Mitchell MD: Developmental origins of health and disease: reducing the burden of chronic disease in the next generation. Genome Med. 2(2), 14 (2010).
7. Gluckman PD, Hanson MA, Cooper C, Thornburg KL: Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359(1), 61-73 (2008).
8. Ehrlich M: DNA methylation in cancer: too much, but also too little. Oncogene 21(35), 5400-5413 (2002). (Pubitemid 34983477)
9. Kulis M, Esteller M: DNA methylation and cancer. Adv. Genet. 70, 27-56 (2010).
10. De Smet C, Loriot A: DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics 5(3), 206-213 (2010).
11. Baccarelli A, Bollati V: Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 21(2), 243-251 (2009).
12. Hochberg Z, Feil R, Constancia M et al.: Child health, developmental plasticity, and epigenetic programming. Endocr. Rev. doi: 10.1210/ er.2009-0039 (2010) (Epub ahead of print).
13. Guerrero-Preston R, Goldman LR, Brebi-Mieville P et al.: Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 5(6), (2010) (Epub ahead of print).
14. Kalari S, Pfeifer GP: Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv. Genet. 70, 277-308 (2010).
15. Faulkner GJ, Kimura Y, Daub CO et al.: The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet. 41(5), 563-571 (2009).
16. Wolff EM, Byun HM, Han HF et al.: Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 6(4), e1000917 (2010).
17. Feinberg AP, Irizarry RA: Evolution in health and medicine Sackler colloquium: stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc. Natl Acad. Sci. USA 107(Suppl. 1), 1757-1764 (2010).
18. Feinberg AP, Irizarry RA, Fradin D et al.: Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci. Transl. Med. 2(49), 49ra67 (2010).
19. Handel AE, Ramagopalan SV: Is Lamarckian evolution relevant to medicine? BMC Med. Genet. 11, 73 (2010).
20. Ehrlich M: DNA hypomethylation in cancer cells. Epigenomics 1(2), 239-259 (2009).